Effectiveness and safety of tofacitinib<i>versus</i>calcineurin inhibitor in interstitial lung disease secondary to anti-MDA5-positive dermatomyositis: a multicentre cohort studyWanlong Wu, Shuang Ye, Wei Fan et al.|European Respiratory Journal|2025Cited by 48